Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

accord healthcare, inc. - cinacalcet hydrochloride (unii: 1k860wsg25) (cinacalcet - unii:uaz6v7728s) - cinacalcet tablets are indicated for the treatment of secondary hyperparathyroidism (hpt) in adult patients with chronic kidney disease (ckd) on dialysis [see clinical studies ( 14.1 )]. limitations of use: cinacalcet tablets are not indicated for use in patients with ckd who are not on dialysis because of an increased risk of hypocalcemia  [see warnings and precautions ( 5.1 )] . cinacalcet tablets are indicated for the treatment of hypercalcemia in adult patients with parathyroid carcinoma [see clinical studies ( 14.2 )] . cinacalcet tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary hpt for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy [see clinical studies ( 14.3 )] . cinacalcet tablets treatment initiation is contraindicated if serum calcium is less than the lower limit of the normal range [see warnings and precautions ( 5.1 )]. risk summary limited case report

Irland - Englisch - HPRA (Health Products Regulatory Authority)

rowex ltd - cinacalcet hydrochloride - film-coated tablet - 30 milligram(s) - other anti-parathyroid agents; cinacalcet

Irland - Englisch - HPRA (Health Products Regulatory Authority)

rowex ltd - cinacalcet hydrochloride - film-coated tablet - 60 milligram(s) - other anti-parathyroid agents; cinacalcet

Irland - Englisch - HPRA (Health Products Regulatory Authority)

rowex ltd - cinacalcet hydrochloride - film-coated tablet - 90 milligram(s) - other anti-parathyroid agents; cinacalcet

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - cinacalcet - film-coated tablet - 30 milligram(s) - other anti-parathyroid agents; cinacalcet

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - cinacalcet - film-coated tablet - 60 milligram(s) - other anti-parathyroid agents; cinacalcet

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - cinacalcet - film-coated tablet - 90 milligram(s) - other anti-parathyroid agents; cinacalcet

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

cadila healthcare limited - cinacalcet hydrochloride (unii: 1k860wsg25) (cinacalcet - unii:uaz6v7728s) - cinacalcet hydrochloride tablets are indicated for the treatment of secondary hyperparathyroidism (hpt) in adult patients with chronic kidney disease (ckd) on dialysis [see clinical studies (14.1)] . limitations of use : cinacalcet hydrochloride tablets are not indicated for use in patients with ckd who are not on dialysis because of an increased risk of hypocalcemia [see warnings and precautions (5.1)]. cinacalcet hydrochloride tablets are indicated for the treatment of hypercalcemia in adult patients with parathyroid carcinoma [see clinical studies (14.2)]. cinacalcet hydrochloride tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary hpt who are unable to undergo parathyroidectomy [see clinical studies (14.3)] . cinacalcet treatment initiation is contraindicated if serum calcium is less than the lower limit of the normal range [see warnings and precautions (5.1) ]. risk summary limited case reports of cinacalcet use in pregnant women are insufficient to inform a d

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - cinacalcet hydrochloride (unii: 1k860wsg25) (cinacalcet - unii:uaz6v7728s) - cinacalcet hydrochloride tablets are indicated for the treatment of secondary hyperparathyroidism (hpt) in adult patients with chronic kidney disease (ckd) on dialysis [see clinical studies (14.1)] . limitations of use : cinacalcet hydrochloride tablets are not indicated for use in patients with ckd who are not on dialysis because of an increased risk of hypocalcemia [see warnings and precautions (5.1)]. cinacalcet hydrochloride tablets are indicated for the treatment of hypercalcemia in adult patients with parathyroid carcinoma [see clinical studies (14.2)]. cinacalcet hydrochloride tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary hpt who are unable to undergo parathyroidectomy [see clinical studies (14.3)] . cinacalcet treatment initiation is contraindicated if serum calcium is less than the lower limit of the normal range [see warnings and precautions (5.1) ]. risk summary limited case reports of cinacalcet use in pregnant women are insufficient to inform a d

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

actavis pharma, inc. - cinacalcet hydrochloride (unii: 1k860wsg25) (cinacalcet - unii:uaz6v7728s) - cinacalcet hydrochloride tablets are indicated for the treatment of secondary hyperparathyroidism (hpt) in adult patients with chronic kidney disease (ckd) on dialysis [see clinical studies (14.1)] . limitations of use: cinacalcet hydrochloride tablets are not indicated for use in patients with ckd who are not on dialysis because of an increased risk of hypocalcemia [see warnings and precautions (5.1)] . cinacalcet hydrochloride tablets are indicated for the treatment of hypercalcemia in adult patients with parathyroid carcinoma [see clinical studies (14.2)] . cinacalcet hydrochloride tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary hpt who are unable to undergo parathyroidectomy [see clinical studies (14.3)] . cinacalcet treatment initiation is contraindicated if serum calcium is less than the lower limit of the normal range [see warnings and precautions (5.1)] . risk summary limited case reports of cinacalcet use in pregnant women are insufficient to inform a dr